학술논문
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
Document Type
Article
Author
De Groot, J.; Penas-Prado, M.; Alfaro-Munoz, K.; Hunter, K.; Pei, B.L.; O'Brien, B.; Weathers, S.-P.; Loghin, M.; Kamiya Matsouka, C.; Yung, W.K.A.; Wu, J.; Yuan, Y.; Zhou, S.; Fuller, G.N.; Huse, J.; Rao, G.; Weinberg, J.S.; Prabhu, S.S.; McCutcheon, I.E.; Lang, F.F.; Ferguson, S.D.; Sawaya, R.; Heimberger, A.B.; Colen, R.; Yadav, S.S.; Blando, J.; Vence, L.; Allison, J.; Sharma, P.; Mandel, J.
Source
In: Neuro-Oncology . (Neuro-Oncology, 15 April 2020, 22(4):539-549)
Subject
Language
English
ISSN
15235866
15228517
15228517